However, other studies claim that blocking CMA-mediated HIF1α degradation induces resistance to TMZ (Lo Dico et al., 2018) and that TMZ resistant cells are unable to increase cytoplasmic ROS levels and activate CMA, preventing thus GBM cell toxicity (Lo Dico et al., 2019). Here, HIF1A is linked to glioblastoma.